Investigational Drug Information for Velusetrag
✉ Email this page to a colleague
What is the development status for investigational drug Velusetrag?
Velusetrag is an investigational drug.
There have been 4 clinical trials for Velusetrag.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2014.
The most common disease conditions in clinical trials are Gastroparesis, Intestinal Pseudo-Obstruction, and Alzheimer Disease. The leading clinical trial sponsors are Theravance Biopharma, Theravance Biopharma R & D, Inc., and Alfasigma S.p.A.
There are six US patents protecting this investigational drug and one hundred and seventy-seven international patents.
Summary for Velusetrag
| US Patents | 6 |
| International Patents | 177 |
| US Patent Applications | 47 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 2 (2014-12-01) |
| Vendors | 19 |
Recent Clinical Trials for Velusetrag
| Title | Sponsor | Phase |
|---|---|---|
| Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). | Alfasigma S.p.A. | Phase 2 |
| The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | Alfa Wassermann S.p.A. | Phase 2 |
| The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study | Alfasigma S.p.A. | Phase 2 |
Clinical Trial Summary for Velusetrag
Top disease conditions for Velusetrag
Top clinical trial sponsors for Velusetrag
US Patents for Velusetrag
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Velusetrag | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| Velusetrag | ⤷ Try a Trial | Organic compounds | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| Velusetrag | ⤷ Try a Trial | Pyrazolo[5,1b]oxazole derivatives as CRF-.sub.1 receptor antagonists | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| Velusetrag | ⤷ Try a Trial | Organic compounds | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| Velusetrag | ⤷ Try a Trial | Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| Velusetrag | ⤷ Try a Trial | Cyclohexyl amide derivatives as CRF receptor antagonists | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Velusetrag
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Velusetrag | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try a Trial |
| Velusetrag | Japan | JP2019520866 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
